Nicole Yates - Zurich Insurance Head Australia
| 0QP2 Stock | 552.00 3.70 0.67% |
Executive
Nicole Yates is Head Australia of Zurich Insurance Group
| Address | Mythenquai 2, Zurich, Switzerland, 8002 |
| Phone | 41 44 625 25 25 |
| Web | https://www.zurich.com |
Zurich Insurance Management Efficiency
The company has return on total asset (ROA) of 0.0332 % which means that it generated a profit of $0.0332 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2069 %, meaning that it generated $0.2069 on every $100 dollars invested by stockholders. Zurich Insurance's management efficiency ratios could be used to measure how well Zurich Insurance manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Zurich Insurance's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 497.4 B in 2024, despite the fact that Other Assets are likely to grow to (202 B).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Chris Judd | Diversified Energy | N/A | |
| Markus Danielson | Coor Service Management | N/A | |
| Mark Kirkendall | Diversified Energy | N/A | |
| John Crook | Diversified Energy | 65 | |
| Katarina Andersson | Coor Service Management | N/A | |
| Doron Zilberman | Surgical Science Sweden | 62 | |
| Fiona Bor | Mereo BioPharma Group | N/A | |
| Michael Rigg | Diversified Energy | N/A | |
| Christine CPA | Mereo BioPharma Group | 43 | |
| Sofia Nilsson | Coor Service Management | N/A | |
| Teresa Odom | Diversified Energy | N/A | |
| Anna Ahlberg | Surgical Science Sweden | 54 | |
| Suba Krishnan | Mereo BioPharma Group | 59 | |
| Jeffrey Berkley | Surgical Science Sweden | 55 | |
| Douglas Kris | Diversified Energy | N/A | |
| William Kurtz | Diversified Energy | 57 | |
| Jens Rasmussen | Coor Service Management | 56 | |
| Inbal MazorBadichi | Surgical Science Sweden | 55 | |
| Charlotte Almberg | Coor Service Management | N/A | |
| Maverick Bentley | Diversified Energy | N/A | |
| Tom Englund | Surgical Science Sweden | 48 | |
Management Performance
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0332 |
Zurich Insurance Leadership Team
Elected by the shareholders, the Zurich Insurance's board of directors comprises two types of representatives: Zurich Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zurich. The board's role is to monitor Zurich Insurance's management team and ensure that shareholders' interests are well served. Zurich Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zurich Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Committee | ||
| Alex Koslowski, Head UK | ||
| Chris Howard, Head US | ||
| George Quinn, Group Committee | ||
| Ericson Chan, Group Committee | ||
| Steve Collinson, Head UK | ||
| Stephan Vliet, Group Committee | ||
| Stephane Baj, Head AH | ||
| Tulsi Naidu, CEO Committee | ||
| Ian Thompson, Group Officer | ||
| Laurence Maurice, CEO Committee | ||
| Alison Martin, CEO Committee | ||
| Walter Kiceleff, Head Distribution | ||
| Sierra Signorelli, CEO Committee | ||
| Mario Greco, Group Committee | ||
| Kristof Terryn, CEO Committee | ||
| Claudia Cordioli, Group Committee | ||
| Jeffrey Dailey, Inc Group | ||
| Nicole Yates, Head Australia | ||
| Katja Pellanda, Group Counsel | ||
| Peter Giger, Group Committee | ||
| Jonathan Hocking, Head Management | ||
| Giovanni Giuliani, Innovation Strategy | ||
| Scott Toland, Chief EMEA |
Zurich Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zurich Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0332 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 65.53 B | |||
| Shares Outstanding | 148.63 M | |||
| Shares Owned By Insiders | 0.21 % | |||
| Shares Owned By Institutions | 42.80 % | |||
| Price To Sales | 0.78 X | |||
| Revenue | 69.96 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Zurich Stock Analysis
When running Zurich Insurance's price analysis, check to measure Zurich Insurance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zurich Insurance is operating at the current time. Most of Zurich Insurance's value examination focuses on studying past and present price action to predict the probability of Zurich Insurance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zurich Insurance's price. Additionally, you may evaluate how the addition of Zurich Insurance to your portfolios can decrease your overall portfolio volatility.